Eptifibatide labels and packages

Revision as of 02:14, 6 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Eptifibatide}} {{CMG}}; {{AE}} {{SS}} ==Labels And Packages== {| |- |thumb|800px |- |} {| |- |thumb|800px...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Eptifibatide
INTEGRILIN® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Eptifibatide
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels And Packages

[1]


References

  1. ↑ "INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]". Retrieved 5 February 2014.

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Eptifibatide_labels_and_packages&oldid=939080"